Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-04

Clinical Trial Update: A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients [Phase 2]

View source ↗

Summary

A Phase 2 pilot study evaluated the effects of Exenatide on body weight in non-diabetic obese patients, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: AstraZeneca | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2009-09-04